Injectsense IOP Sensor Nets FDA Breakthrough Device Program Designation

September 2nd, 2020 EMERYVILLE, Calif., September 1, 2020 -- Injectsense, a company focused on sensor-enabled digital health, announced it has received a Breakthrough Device Program (BDP) designation from the U.S. Food and Drug Administration (FDA) for its chronic continuous IOP monitoring system for glaucoma patients.  The company’s IOP Connect™...